Purpose—Symptomatic intracranial hemorrhage (sICH) is the most feared complication of
intravenous thrombolytic therapy in acute ischemic stroke. Treatment of sICH is based on …

Purpose—The aim of this statement is to review the current data and to make suggestions
for the diagnosis and management of both ruptured and unruptured brain arteriovenous …

Purpose—The aim of this guideline is to present current and comprehensive
recommendations for the diagnosis and treatment of spontaneous intracerebral …

The aim of this updated guideline is to provide comprehensive and timely evidence-based
recommendations on the prevention of future stroke among survivors of ischemic stroke or …

Background Intraventricular haemorrhage is a subtype of intracerebral haemorrhage, with
50% mortality and serious disability for survivors. We aimed to test whether attempting to …

Importance Although use of oral anticoagulants (OACs) is increasing, there is a substantial
lack of data on how to treat OAC-associated intracerebral hemorrhage (ICH). Objective To …

Background: Although in vitro studies and investigations in animal models and small clinical
populations have suggested that ceramides may represent an intermediate link between …

Introduction Evidence-based recommendations are needed to guide the acute management
of the bleeding trauma patient. When these recommendations are implemented patient …

Importance Many patients with severe stroke have impaired airway protective reflexes,
resulting in prolonged invasive mechanical ventilation. Objective To test whether early vs …

Intracerebral haemorrhage (ICH) is the most devastating type of stroke and is a leading
cause of disability and mortality. By contrast with advances in ischaemic stroke treatment …